1. Introduction
The utilization of digital health in pediatric care offers an opportunity to leverage technology for connecting patients and families with expert healthcare providers, mitigating costs and risks associated with hospital-based care [
1]. Connected health, encompassing telecare, telemedicine, telehealth, m-Health, e-Health, and digital health services, has experienced substantial growth in pediatrics, addressing healthcare access disparities and overcoming social and geographic barriers [
2,
3].
As the shift toward home-based care supported by technology continues, patients and family caregivers need to understand and assume greater responsibilities for this new care model [
4,
5].
Recently, innovative “hospital at home” (HaH) initiatives have been developed to connect home-based care with hospital services, utilizing Technology-Enabled Care (TEC) for improved patient care and self-management. Kanagala et al. [
6] reported that HaH care can result in lower median length of stay and readmission rates, offering a flexible model adaptable to varying demand situations with better clinical outcomes. Beyond economic considerations, early hospital discharge is crucial for optimizing care, especially in pediatric settings. The “European Association for Children in Hospital Charter” emphasizes the necessity of hospital admission only when essential, advocating for the prompt discharge of hospitalized children to ensure their psychophysical well-being [
7].
Mobile technology is increasingly prevalent in healthcare [
8,
9], serving various purposes, including remote health monitoring and patient self-management, which could prove beneficial for early hospital discharges with significant psychosocial and economic impacts.
A user-friendly device refers to a device that is easy and intuitive to use, designed to accommodate the needs of a diverse range of users, including those with limited abilities or technological skills. A user-friendly mobile device, the TytoCare™ system, functions as both an otoscope and stethoscope [
10,
11,
12]. Enabling remote examinations of ears, throat, skin, heart, and lungs, it supports the transmission of examination data from caregivers or healthcare professionals to physicians, overcoming obstacles to telemedicine integration.
Although limited, existing data on user-friendly mobile device use in pediatrics show promise. Wagner et al. [
13] demonstrated concordance between measurements from remote physical examinations with a mobile medical device and in-person examinations in children older than 2 years. McDaniel et al. [
14] highlighted superior sound and image quality compared to stand-alone devices, reducing diagnostic limitations. Notario et al. [
15] demonstrated the feasibility and positive reception of in-home telehealth mobile devices, leading to reduced hospitalizations compared to usual care.
This study aims to explore the experience of a transitional care program using a user-friendly mobile medical device (TytoCare™, TytoCare Ltd., Natanya, Israel) to facilitate early hospital discharges in a pediatric environment. User and physician experience surveys will contribute valuable insights, furthering our understanding of the role of mobile medical devices as enablers in the perspective of HaH healthcare in pediatrics.
2. Methods
2.1. Study Design and Randomization
Before the start of a study, researchers should develop a detailed randomization protocol outlining the procedures for assigning participants to different treatment groups.
This study employed a single-center, two-group, randomized, open-label design with parallel arms conducted at Buzzi Children’s Hospital, situated in the metropolitan area of Milan, Italy. The experimental group involved early discharge with telehomecare (TELE), while the standard care (STAND) group received in-person physical care until the completion of hospitalization.
All patients/caregivers admitted from November 2022 to July 2023 who met the eligibility criteria were offered participation in the project. Those who agreed to engage in telemedicine were enrolled and subjected to randomization.
Informed consent was obtained and the allocation sequence, which was generated using a randomization procedure, assigned the participants to different groups. The randomization was executed in a 1:1 ratio (TELE/STAND) through a computer-generated number determinant. A physician who was unrelated to the process created a registration form to document it. Treatment allocation remained unblinded to both subjects and physicians.
Children declining participation in the telemedicine project continued with standard treatment. The study process adhered to the Consolidated Standards of Reporting Trials guidelines, as illustrated in
Figure 1. The protocol was registered in the Clinical Trials Registry clinicaltrials.gov (NCT06171763) (accessed on 20 December 2023).
Periodic review of documentation and verification of data integrity were scheduled during the study.
2.2. Participants
Participants in the present study were consecutively enrolled at the Buzzi Children’s Hospital (Milano, Italy) in the Pediatric Unit, Pediatric Surgery Unit, and Palliative Care Unit, and dyads of the hospitalized patient and family caregiver were recruited.
Inclusion criteria:
Age of enrolled subjects: 0–18 years.
Gender of patients (males and females).
Patient status: hospitalized at the completion of treatment.
Stability in vital signs (heart rate, respiratory rate, oxygen saturation).
Stability/improvement/resolution in biochemical tests.
No fever.
Consent/Assent: participants must be willing and provide appropriate consent or assent based on their age.
Proximity to domicile: living within a maximum 45 min distance from the facility.
Adequate home environment
Language proficiency: adequate proficiency in the Italian language.
Possession of a compatible device.
Exclusion criteria:
Refusal to participate in the program.
Instability in vital signs.
Presence of fever.
Deteriorating results in biochemical tests.
Living more than 45 min away from the facility.
Inadequate home facilities.
Language barrier.
Lack of possession of a compatible device.
Not having a device with an operating system capable of supporting the Tytocare app 7.0.0.433.
Parental consent was obtained from all participants or their responsible guardians after a thorough explanation of the study’s purpose. The study was conducted in accordance with the Declaration of Helsinki guidelines and approved by the Ethics Committee Milano Area 1 (Protocol number n. 0033846, date 3 August 2022). A medical team of 14 professionals were trained in the use of the TytocareTM device and voluntarily agreed to participate in the project.
2.3. Intervention
The telehomecare intervention entails an early hospital discharge with ongoing home monitoring utilizing a user-friendly mobile device (TytoCare™). Additionally, an in-person clinical reassessment was conducted 72 h after discharge to evaluate intervention outcomes.
Patient instructions were developed and shared to facilitate access to and download of medical reports, promoting patient engagement and empowerment in managing their healthcare.
2.3.1. Experimental Group: Telehomecare
For patients/caregivers allocated to the TELE group, healthcare personnel trained in TytoCare™ system usage provided instructions before discharge. Subsequently, each patient received a device for use until the scheduled post-discharge clinical assessment. A parent or caregiver was invited to participate for each pediatric patient.
Every 24 h, remote synchronous teleconsultation assessed the patient, with the physician using the TytoCare™ device for a comprehensive routine procedure, including medical history and physical examination. Data collection sheets were completed during the tele-visit.
At the 72 h post-discharge mark, an in-person clinical assessment was scheduled to evaluate outcomes. Specifically, the visit evaluated the complete resolution of the disease state through a post-discharge objective examination.
TytoCare™ is a registered medical device compliant with European Medical Device Directive 93/42/EEC. The certificate of conformity and technical datasheet are provided in
Supplementary Material S1.
The TytoCare™ System served as the remote physical examination tool. This device enabled patients to conduct examinations and transmit audio, video, or image data to medical professionals located remotely; the TytoCare™ Device establishes a connection with an application on the patient’s mobile device to facilitate the communication of examination data and enable online meetings with clinicians. TytoCare™ is a modular, all-in-one device that encompasses functions such as a stethoscope, otoscope, tongue depressor, and thermometer:
- -
Stethoscope: Frequency range of 20–3500 Hz, heart rate range of 30–250 BPM, dimensions of 40 × 39 mm, and a weight of 0.06 kg.
- -
Otoscope: Image resolution of 640 × 480 (VGA), weight of 0.02 kg, and an adaptable speculum for children (3 mm).
- -
Tongue Depressor: For children (60 mm), weight of 0.011 kg.
- -
Thermometer: Detection range of 34.4–42.2 °C; accuracy of 0.2 °C for the temperature range 38–41 °C, with a precision of 0.2 degrees Celsius within the range of 38 to 41 degrees Celsius and a precision of 0.3 degrees Celsius outside this range (compliant with ASTM E1965-98 [
16] and ISO 80601-2-56 [
17]).
2.3.2. Non-Intervention Group: Standard Care
Patients in the STAND group remained hospitalized for ongoing treatment. Every 24 h, in-person assessments by medical staff included a traditional physical examination utilizing standard equipment such as a digital thermometer, conventional stethoscope, and otoscope. The same data collection sheet was completed during these assessments. After 72 h of hospital observation, an in-person clinical examination was conducted to evaluate outcomes, specifically assessing the complete resolution of the disease state through a post-discharge objective examination.
Additionally, a group of 51 children declining telemedicine service (NO-TELE) was included in the study to record the reasons for refusal.
2.4. Outcomes
Considering in-person visits as the standard care procedure, the primary objective is to achieve concordance with complete resolution of the disease through in-person physical care without readmission to the hospital, expecting non-readmission in a minimum of 90% of cases. Secondary objectives include recording a lower length of stay in the interventional group. User and professional experience surveys were conducted to evaluate the level of acceptance and satisfaction with the telehomecare model.
2.5. Sample Size
A sample size of 50 in each randomized group achieves 80% power to detect a non-inferiority margin difference between group proportions of −0.0800. The reference group proportion is 0.9800, and the interventional group proportion is assumed to be 0.9000 under the null hypothesis of inferiority. The power was computed for the case when the standard treatment group proportion is 0.9889. The test statistic used is the one-sided Score test (Farrington and Manning). The significance level targeted for the test was 0.0500, and the achieved significance level by this design is 0.0465.
2.6. User and Physician Survey Questions
After randomization, in both the TELE and STAND groups, a user survey was distributed (see
Table 1). The survey consisted of self-administered questions categorized into five sections, covering the following topics:
Sociodemographic information about the children and parents.
Employment details of parents who work.
Distance between home and the hospital.
Parents’ knowledge, attitudes, and technological skills in utilizing technologies, digital communication systems, and telehealth services [
18,
19,
20].
Additionally, a survey on the perceived disadvantages and advantages of using the telemedicine option was recorded (see
Table 2) [
18,
19,
20].
Exclusively within the TELE group, supplementary data were gathered post-intervention to assess user satisfaction and the perceived level of care utilizing the Tytocare device (see
Table 3).
In the TELE and STAND groups, the surveys were handed out immediately after randomization and then collected at the 72 h point during in-person clinical assessment.
Within the group of patients who declined the telemedicine service, a self-administered survey was recorded to identify factors that might have impeded their engagement and utilization of the proposed technological tools (see
Table 4).
In all patients, a self-administered survey on the satisfaction level of the hospitalization experience was also recorded (see
Table 5).
A physician experience survey was also self-administered at the conclusion of the study and was taken into consideration for this study’s purpose (see
Table 6).
4. Results
As reported in
Figure 1, during the consecutive enrollment period, the project was presented to 153 hospitalized patients (86 males, 67 females, mean age 3.37 ± 4.0 years).
Among them, 102 patients accepted the telemedicine solution and were subsequently randomized, while the remaining 51 patients declined the telemedicine option.
4.1. Randomized Telehomecare and Standard Care Groups
A total of 102 children (59 males and 43 females, mean age of 3.36 ± 3.98 years), affected by respiratory diseases (56.9%) (bronchiolitis, pneumonia, asthma, upper airways disorders), abdominal pathologies (17.6%) (gastroenteritis, colitis, appendicitis, stones) and other pathologies (21.5%) (osteomyelitis, uro-genital and other infections, endocrine problems, burns) accepted the telemedicine service.
These patients were randomly assigned to the TELE group (
n = 51) or the STAND group (
n = 51), as illustrated in
Figure 1.
4.1.1. Clinical Outcomes
In a comparable manner to the STAND group, a total of 51/51 (100%) children included in the TELE arm reached complete resolution of disease during the telemedicine intervention, without readmission to the hospital.
An adequate transmission of clinical parameters with mobile devices was obtained in all children. No significant technical problems occurred during telemonitoring (
Table 3).
With home telemonitoring, the median length of hospital stay was 4 days (IQR 3–8) in the interventional group, significantly shorter than 7 days (IQR 5–9) in the STAND group (p = 0.01).
4.1.2. User Survey Results in Randomized Groups
All enrolled participants successfully completed the survey.
Table 1 illustrates the survey questionnaire along with the corresponding responses.
The TELE and STAND groups exhibited no significant difference in terms of sociodemographic characteristics, as well as the parents’ proficiency in utilizing technologies, digital communication systems, and telehealth services.
In both groups, in most cases, the survey was completed by the mother (TELE: 84.32%, STAND: 94.12%) who had a regular job (TELE: 72.5%, STAND: 76.47%).
Respondents generally had a high level of education (TELE: 86.0%, STAND: 92.16%) and demonstrated excellent or good competence in using digital technologies (82.35%). Internet access at home was usually used every day (100%). Only 13.73% of cases in TELE and 8.33% in STAND had previous telemedicine experience.
In
Figure 2, the main knowledge, attitudes and skills of the parents in using technologies, digital communication systems and telehealth services are shown.
In
Table 2, the disadvantages and advantages of using telemedicine options are reported. In both groups, the main possible limitation of telemedicine is the lack of personal contact with doctors, and in more than 80% of cases, a tele-visit was not considered as reliable as a real visit.
As reported in
Figure 3, the main motivations for using telemedicine included time (90%) and money in travel and permits (87.76%), relevance to stay at home (90%), technology safety and utility (98%), significant trust in the professionalism of the service providers (96.9%).
In
Table 3, the satisfaction survey for the TELE group in using the telemedicine option is presented. The TELE users were very satisfied or satisfied in all areas on training in using, including operational steps (91.49%), contact (91.49%), therapeutic indications (87.24%), support (89.13%).
All respondents reported satisfaction with the telemedicine experience (100%); no dissatisfaction was expressed (0%). In the 97.87% of cases, parents are able to correctly describe the child’s health information, sharing the parameters without technical problems (100%). Additionally, 93.75% of the respondents stated they would repeat the telemedicine experience.
4.2. No-Telemedicine Group
A total of fifty-one patients (27 males and 24 females), affected by respiratory diseases 64.7%, abdominal pathologies 13.7% and other disorders 21.6%, with a mean age of 3.47 ± 4.04 years, comprised the NO-TELE group.
There is no statistically significant difference in demographic data and types of diseases between the group that declined the telemedicine option and the groups that accepted the telemedicine solution. All patients achieved full recovery from the disease during their hospitalization.
Table 1 and
Table 3 present the survey questionnaire along with the corresponding responses of patients in the NO-TELE group.
Upon comparison with the group that embraced the telemedicine option, no significant differences were observed in terms of age and demographic features. The majority demonstrated excellent or good competence in using digital technologies (78%) and reported regular daily Internet use at home (97.56%).
The primary reasons for declining the telemedicine option included the inability to establish a personal relationship with the medical doctor (95.45%) and the incapacity to ask the medical doctor questions directly (93.18%). Respondents expressed concerns about the reliability of tele-consultations compared to in-person visits (97.73%) and showed a preference for traditional hospitals as the optimal care structure (97.83%). Worries about privacy issues (68.89%), difficulties in using technology (84.09%), and potential technical problems (68.18%) were also cited as limiting factors. Despite the current refusal of the telemedicine option, 40.82% of cases did not rule out the possibility of using the service in the future.
4.3. Patient Satisfaction Level of the Hospitalization Experience
In
Table 4, the survey results on the hospitalization experience in all groups are presented. In all, the level of patient satisfaction is high, with no significant differences observed between the groups.
4.4. Physician Survey Results
As reported in
Table 6, 96.15% of physicians expressed satisfaction with the adopted system. During tele-visits, no or limited technical problems, immediately resolved (temporary audio problems), were detected in 78.85% of cases; in the remaining 21.15%, temporary connection problems were recorded. Comfortable communication (100%) and useful data sharing with parents (94.23%) were reported, with no issues in following-up instructions (94.24%) and with adequate adherence to the agreed-upon time (98.08%).
5. Discussion
Our study underscores the utility of user-friendly mobile medical devices, exemplified by the TytoCare™ system, in effectively reducing hospital stays while achieving optimal clinical outcomes comparable to standard care. The system showed proficient performance in transmitting clinical information during telehealth visits, earning high levels of satisfaction from both patients and physicians. These mobile medical devices serve as a valuable bridge between home and hospital, optimizing care pathways.
Hospitalization can be an inherently stressful experience for children, impacting behavioral and emotional responses with potential implications for health and developmental outcomes [
21]. Hospitalized children may undergo a disconnection from their familiar family surroundings and recreational activities, navigating an environment where they encounter unfamiliar and invasive medical procedures [
22]. These alterations can be perceived as traumatic events, eliciting stress responses. In certain instances, susceptibility to stress, clinical conditions, and care-related characteristics may contribute to the onset of Pediatric Medical Traumatic Stress, resulting in enduring negative psychological effects [
23,
24]. The risks associated with these stressors are particularly pronounced in cases of chronic illnesses, conditions involving frequent or prolonged hospitalizations, or in the presence of psychosocial vulnerability [
25]. Furthermore, the hospitalization of a child is a stressful event for parents as well [
24]. Parents often grapple with anxiety and depression during the hospitalization period, especially in families with children facing chronic pathologies [
26,
27], leading to significant implications for the child’s health and behavioral outcomes [
24,
26,
27].
Improving the hospital discharge process as highlighted by the “European Association for Children in Hospital Charter” [
7] is crucial in pediatric care, aligning with the imperative to discharge children promptly for their psychophysical well-being [
28]. Telemedicine, as a bridge between home and hospital, emerges as a promising tool, though the literature on its role in early hospital discharge is limited [
29,
30]. Vesterby et al. [
29] reported that telemedicine support shortens length of stay after fast-track hip replacement in adults. Minguez Clemente et al. [
31] demonstrated that follow-up through a telemedicine program after early discharge from hospitalization is equally effective as conventional home follow-up in patients with chronic obstructive pulmonary disease. Our study contributes valuable insights by demonstrating a significant reduction in hospital stays through the use of a mobile medical device in a pediatric setting. This suggests that a telemedicine approach allows for quicker discharges without compromising clinical safety or physical outcomes, thereby enhancing the quality of children’s care.
Ensuring timely discharge and preventing readmissions are crucial indicators of effective integration between hospital and community services [
32]. The use of a user-friendly mobile medical device not only led to a reduction in hospital stays but also ensured satisfactory clinical outcomes without instances of readmission, supporting the effectiveness of home telecare. This highlights the role of mobile remote presence devices as integrative tools for remote patient monitoring, supporting the evolution of family-centered care [
30]. A hybrid “home–hospital” model could be seen as a prospective approach in pediatric care for “vulnerable” children, including those with chronic illnesses and medical fragility.
These populations, which have a high priority for health services and technological support systems, could greatly benefit from this approach to address their multiple health needs [
8].
Our study participants expressed satisfaction with TytoCare
TM, even if they were initially unfamiliar with the concept. The positive experiences reported, coupled with a willingness to recommend the service, emphasize the potential of these technologies in healthcare. Trust in professional service emerged as a crucial factor influencing user satisfaction and perceived care levels, underscoring the need for integrating technological innovation into medical training, as emphasized by Chastonay et al. [
33].
Perceived benefits of telemedicine, including time and cost savings, reduced hospital stays, and technology utility and usability, align with the evolving landscape of healthcare delivery. While limitations were reported by some individuals opting against telemedicine, our findings overall support the positive impact of mobile medical devices in pediatric care, fostering patient satisfaction and efficient healthcare delivery. The telemedicine option leads to a lack of personal contact with one’s medical doctor during telemedicine services. These results confirm that some disadvantages of telehealth include limitations with performing comprehensive physical examinations with impersonal interactions with physicians [
3].
Telemedicine must deal with many legal and regulatory obstacles [
9]. Even though our users expressed limited privacy concerns, regulatory frameworks for telemedicine are insufficient, often lacking clarity [
3]. The ethical responsibilities, conflict of interest considerations, and obligations to protect personal health information are the same for practicing telemedicine as they are for practicing in-person medicine; thus, regulatory, legal, and ethical considerations of telemedicine should be taken into account. However, at this time, particularly concerning healthcare and medical practice, uniform regulations at the European level are absent [
3]. The wide range of norms and regulations governing practice and privacy contributes to confusion for providers involved in telemedicine practice [
3].
According to the literature [
34], we recorded high levels of physician satisfaction utilizing telemedicine. Telemedicine utilizing mobile devices can serve as an additional tool to facilitate a broader and more enduring adoption of telemedicine [
34].
To fully harness the potential of telemedicine and remove the obstacles to its utilization, future research and initiatives are imperative. These should focus on enhancing the long-term satisfaction in using telemedicine and the cost-effectiveness of telemedicine services, ensuring unrestricted access to the internet, and establishing specific guidelines concerning data protection safety, informed consent, and professional liability [
8].
6. Study Limitations
As a pilot study, this research was limited by the small sample size with various diseases at admission; thus, further studies with a larger number of patients are mandatory to confirm the positive role of user-friendly mobile medical devices in early hospital discharges, investigating potential variations among age groups (neonates, infants, children, and adolescents) and types of disease.
We present a randomized study to explore a transitional care program utilizing a user-friendly mobile medical device. Randomization alone did not completely remove the potential for systematic differences between treatment groups in this study. Enthusiasm for a new treatment may lead to improved outcomes being observed in this patient group, irrespective of the actual treatment efficacy. Thus, a blinded or masked trial can help limit bias. However, in some cases, such as in our protocol, the nature of the treatments under investigation makes blinding difficult. Therefore, to mitigate bias related to the open-label design, we applied a meticulous study design and randomization to patients/caregivers who agreed to participate in telemedicine. All steps of the protocol and randomization have been planned and recorded to ensure transparency at every stage, thereby facilitating reproducibility. Additionally, standardized eligibility criteria were applied before randomization.
Additionally, in order to better evaluate user acceptance, additional aspects of user and physician satisfaction should be explored further, also considering that the final timeline of the project and the availability of users and professionals to participate can certainly impact the reported satisfaction levels. The long-term use of the system will help us better understand the factors that most significantly influence the level of satisfaction and adaptability of this technological approach into existing processes, workflows, and practices.
Finally, the viability of the telemedicine service needs to be assessed in relation to cost–benefit considerations, considering both direct and indirect costs for patients, families, organizations, and the healthcare system [
3,
27,
34,
35]. While this project is currently in the exploratory phase, economic evaluation has not yet been incorporated but is planned as a future objective. Specifically, we will evaluate the sustainability of the telemedicine approach, taking into consideration the value that it can generate in social, economic–administrative, and environmental contexts, while considering both the professional/hospital context and that of the user.